Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ1-42-Induced Neurotoxicity in Differentiated SH-SY5Y Cells
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-025-05082-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Hamiyet Eciroglu-Sarban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vocational School of Health Services, Alanya Alaaddin Keykubat University, 07425, Antalya, Türkiye. Hauptthemen laut MEDLINE: Casein Kinase II, Hesperidin, Dichlororibofuranosylbenzimidazole, Alzheimer Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bilimsel Araştırma Projeleri, Erciyes Üniversitesi, Erciyes University.
Abstract (Originalsprache)
There is still no approved treatment for Alzheimer’s disease (AD), a progressive neurodegenerative disorder characterized by amyloid plaques, neurofibrillary tangles, and synaptic dysfunction. In an in vitro AD model, this study aimed to comparatively assess the neuroprotective effects of the citrus flavonoid Hesperidin and the casein kinase 2 (CK2) inhibitor 5,6-dichloro-1-β-D-ribofuranosyl benzimidazole (DRB) as potential therapeutic targets for AD. First, SH-SY5Y neuroblastoma cells were differentiated into cholinergic neuron-like cells using all -trans retinoic acid (RA) and brain-derived neurotrophic factor (BDNF). Then, to generate an in vitro AD model, 20 μM Aβ 1–42 was applied to induce neurotoxicity in differentiated SH-SY5Y cells. The neuroprotective effects of the CK2 inhibitor DRB and Hesperidin on the in vitro AD model were evaluated using MTT, RT-qPCR, and ELISA methods. Both Hesperidin and DRB, at high concentrations, reduced cell viability in differentiated SH-SY5Y cells for 24 and 48 h ( p < 0.05 to p < 0.01). Pre-treatment with Hesperidin at 25 and 50 µM and DRB at 0.25 and 0.5 µM for 24 h increased ADAM10 gene expression and decreased BACE1 gene expression, both of which are associated with AD markers, compared to the 20 µM Aβ 1-42 treatment group ( p < 0.05). Pre-treatment with the DRB at 0.25 and 0.5 µM concentrations for 24 h decreased CK2α gene expression in the in vitro AD model compared to the 20 µM Aβ 1-42 treatment group ( p < 0.05), whereas Hesperidin had no effect ( p > 0.05). Both pre-treatment with Hesperidin and DRB significantly decreased Aβ 1-42 levels ( p < 0.01), p-Tau (T181) levels ( p < 0.05), and the Bax/Bcl-2 ratio ( p < 0.05). As a result, our study showed that both Hesperidin and DRB inhibited Aβ production by suppressing the amyloidogenic pathway and activating the non-amyloidogenic pathway while also exerting an inhibitory effect on neuronal apoptosis. CK2 may be a potential therapeutic target and could contribute to the pathophysiology of AD. However, these findings should be validated by further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vocational School of Health Services, Alanya Alaaddin Keykubat University, 07425, Antalya, Türkiye.
- Institute of Health Sciences, Erciyes University, 38030, Kayseri, Türkiye.
- Department of Medical Biology, Medical Faculty, Erciyes University, 38030, Kayseri, Türkiye.
- Department of Pharmacology, Faculty of Pharmacy, Hacettepe University, 06410, Ankara, Türkiye.
- Institute of Health Sciences, Erciyes University, 38030, Kayseri, Türkiye. donmezh@erciyes.edu.tr.
- Department of Medical Biology, Medical Faculty, Erciyes University, 38030, Kayseri, Türkiye. donmezh@erciyes.edu.tr.
Förderung
- Bilimsel Araştırma Projeleri, Erciyes Üniversitesi
- Erciyes University
Zitieren
APA
Eciroglu-Sarban, H., Altin-Celik, P., Kelicen-Ugur, P., & Donmez-Altuntas, H. (2025). Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ1-42-Induced Neurotoxicity in Differentiated SH-SY5Y Cells. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05082-2
Vancouver
Eciroglu-Sarban H, Altin-Celik P, Kelicen-Ugur P, Donmez-Altuntas H. Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ1-42-Induced Neurotoxicity in Differentiated SH-SY5Y Cells. Molecular Neurobiology. 2025. doi:10.1007/s12035-025-05082-2
BibTeX
@article{EcirogluSarban2025,
author = {Eciroglu-Sarban, Hamiyet and Altin-Celik, Pinar and Kelicen-Ugur, Pelin and Donmez-Altuntas, Hamiyet},
title = {Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ1-42-Induced Neurotoxicity in Differentiated SH-SY5Y Cells},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-025-05082-2}
}
EUVIMED